OPNT - Opiant Pharmaceuticals EPS misses by $0.23 beats on revenue March, 04 2021 04:43 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (OPNT): Q4 GAAP EPS of -$0.16 misses by $0.23.Revenue of $10M (+30.4% Y/Y) beats by $0.8M.Shares -3.2%.Press Release For further details see: Opiant Pharmaceuticals EPS misses by $0.23, beats on revenue